nodes	percent_of_prediction	percent_of_DWPC	metapath
Sertindole—CYP2D6—Lomustine—brain cancer	0.131	0.303	CbGbCtD
Sertindole—CYP2D6—Hydroxyurea—brain cancer	0.0989	0.23	CbGbCtD
Sertindole—CYP3A4—Temozolomide—brain cancer	0.0976	0.227	CbGbCtD
Sertindole—CYP3A4—Lomustine—brain cancer	0.083	0.193	CbGbCtD
Sertindole—HTR1D—meninx—brain cancer	0.0272	0.0619	CbGeAlD
Sertindole—HTR1F—trigeminal nerve—brain cancer	0.0271	0.0617	CbGeAlD
Sertindole—HTR1B—dura mater—brain cancer	0.0258	0.0588	CbGeAlD
Sertindole—HTR1D—dura mater—brain cancer	0.025	0.0569	CbGeAlD
Sertindole—HTR2C—choroid plexus—brain cancer	0.0211	0.0479	CbGeAlD
Sertindole—CYP3A4—Etoposide—brain cancer	0.0201	0.0466	CbGbCtD
Sertindole—HTR1B—trigeminal nerve—brain cancer	0.0111	0.0253	CbGeAlD
Sertindole—DRD3—telencephalic ventricle—brain cancer	0.0111	0.0252	CbGeAlD
Sertindole—HTR1D—trigeminal nerve—brain cancer	0.0108	0.0245	CbGeAlD
Sertindole—HTR2A—choroid plexus—brain cancer	0.0106	0.024	CbGeAlD
Sertindole—HTR1F—ganglion—brain cancer	0.00977	0.0223	CbGeAlD
Sertindole—HRH1—nose—brain cancer	0.00815	0.0186	CbGeAlD
Sertindole—HTR1B—cranial nerve—brain cancer	0.00791	0.018	CbGeAlD
Sertindole—HTR1D—cranial nerve—brain cancer	0.00766	0.0174	CbGeAlD
Sertindole—HTR6—ganglion—brain cancer	0.00664	0.0151	CbGeAlD
Sertindole—HTR1B—telencephalic ventricle—brain cancer	0.00643	0.0146	CbGeAlD
Sertindole—HTR1D—telencephalic ventricle—brain cancer	0.00623	0.0142	CbGeAlD
Sertindole—HTR2C—telencephalic ventricle—brain cancer	0.00617	0.014	CbGeAlD
Sertindole—HTR2A—trigeminal nerve—brain cancer	0.00534	0.0122	CbGeAlD
Sertindole—HTR2A—cerebellar cortex—brain cancer	0.00532	0.0121	CbGeAlD
Sertindole—HTR1A—telencephalic ventricle—brain cancer	0.00519	0.0118	CbGeAlD
Sertindole—HTR2A—vein—brain cancer	0.00483	0.011	CbGeAlD
Sertindole—DRD2—telencephalic ventricle—brain cancer	0.00469	0.0107	CbGeAlD
Sertindole—HTR1B—ganglion—brain cancer	0.004	0.00912	CbGeAlD
Sertindole—HTR1D—ganglion—brain cancer	0.00388	0.00883	CbGeAlD
Sertindole—HTR2C—ganglion—brain cancer	0.00384	0.00874	CbGeAlD
Sertindole—HTR2A—cranial nerve—brain cancer	0.00381	0.00866	CbGeAlD
Sertindole—HTR1F—telencephalon—brain cancer	0.00377	0.00858	CbGeAlD
Sertindole—HTR2A—pons—brain cancer	0.00376	0.00856	CbGeAlD
Sertindole—HTR1E—brainstem—brain cancer	0.00368	0.00838	CbGeAlD
Sertindole—SLC6A4—ganglion—brain cancer	0.00364	0.00829	CbGeAlD
Sertindole—HTR1E—telencephalon—brain cancer	0.00327	0.00744	CbGeAlD
Sertindole—HTR1A—ganglion—brain cancer	0.00323	0.00736	CbGeAlD
Sertindole—HTR1B—blood vessel—brain cancer	0.00318	0.00725	CbGeAlD
Sertindole—HTR2A—telencephalic ventricle—brain cancer	0.00309	0.00704	CbGeAlD
Sertindole—HTR1D—blood vessel—brain cancer	0.00308	0.00702	CbGeAlD
Sertindole—DRD2—ganglion—brain cancer	0.00292	0.00665	CbGeAlD
Sertindole—SLC6A4—hindbrain—brain cancer	0.00276	0.00628	CbGeAlD
Sertindole—HTR2A—pineal body—brain cancer	0.00268	0.00611	CbGeAlD
Sertindole—HTR6—telencephalon—brain cancer	0.00256	0.00584	CbGeAlD
Sertindole—HTR1A—hindbrain—brain cancer	0.00245	0.00558	CbGeAlD
Sertindole—HTR1F—head—brain cancer	0.00235	0.00535	CbGeAlD
Sertindole—ADRA1A—hindbrain—brain cancer	0.00226	0.00514	CbGeAlD
Sertindole—DRD2—hindbrain—brain cancer	0.00221	0.00504	CbGeAlD
Sertindole—HTR1F—central nervous system—brain cancer	0.00214	0.00488	CbGeAlD
Sertindole—HTR1E—head—brain cancer	0.00203	0.00463	CbGeAlD
Sertindole—ADRA1D—telencephalon—brain cancer	0.002	0.00456	CbGeAlD
Sertindole—HTR2A—ganglion—brain cancer	0.00193	0.00438	CbGeAlD
Sertindole—HTR1E—central nervous system—brain cancer	0.00186	0.00423	CbGeAlD
Sertindole—Haloperidol—CYP2C9—brain cancer	0.00178	1	CrCbGaD
Sertindole—HTR1B—brainstem—brain cancer	0.00174	0.00396	CbGeAlD
Sertindole—DRD4—brain—brain cancer	0.00171	0.00389	CbGeAlD
Sertindole—HTR1F—brain—brain cancer	0.0017	0.00387	CbGeAlD
Sertindole—HTR1D—brainstem—brain cancer	0.00169	0.00384	CbGeAlD
Sertindole—HTR2C—brainstem—brain cancer	0.00167	0.0038	CbGeAlD
Sertindole—HTR2A—endothelium—brain cancer	0.00166	0.00378	CbGeAlD
Sertindole—DRD3—head—brain cancer	0.00166	0.00377	CbGeAlD
Sertindole—HTR6—head—brain cancer	0.0016	0.00363	CbGeAlD
Sertindole—SLC6A4—brainstem—brain cancer	0.00158	0.0036	CbGeAlD
Sertindole—HTR1B—telencephalon—brain cancer	0.00154	0.00352	CbGeAlD
Sertindole—HTR2A—blood vessel—brain cancer	0.00153	0.00349	CbGeAlD
Sertindole—DRD3—central nervous system—brain cancer	0.00151	0.00345	CbGeAlD
Sertindole—HTR1D—telencephalon—brain cancer	0.0015	0.00341	CbGeAlD
Sertindole—HTR2C—telencephalon—brain cancer	0.00148	0.00337	CbGeAlD
Sertindole—HTR1E—brain—brain cancer	0.00147	0.00336	CbGeAlD
Sertindole—HTR2A—hindbrain—brain cancer	0.00146	0.00333	CbGeAlD
Sertindole—HTR6—central nervous system—brain cancer	0.00146	0.00332	CbGeAlD
Sertindole—HTR1A—brainstem—brain cancer	0.0014	0.0032	CbGeAlD
Sertindole—SLC6A4—telencephalon—brain cancer	0.0014	0.0032	CbGeAlD
Sertindole—CYP2D6—hindbrain—brain cancer	0.00133	0.00303	CbGeAlD
Sertindole—ADRA1A—brainstem—brain cancer	0.00129	0.00295	CbGeAlD
Sertindole—ADRA1B—head—brain cancer	0.00127	0.0029	CbGeAlD
Sertindole—DRD2—brainstem—brain cancer	0.00127	0.00289	CbGeAlD
Sertindole—ADRA1D—endocrine gland—brain cancer	0.00126	0.00287	CbGeAlD
Sertindole—HTR1A—telencephalon—brain cancer	0.00125	0.00284	CbGeAlD
Sertindole—ADRA1D—head—brain cancer	0.00125	0.00284	CbGeAlD
Sertindole—DRD3—brain—brain cancer	0.0012	0.00274	CbGeAlD
Sertindole—HTR2C—medulla oblongata—brain cancer	0.00116	0.00265	CbGeAlD
Sertindole—ADRA1B—central nervous system—brain cancer	0.00116	0.00265	CbGeAlD
Sertindole—HTR6—brain—brain cancer	0.00116	0.00263	CbGeAlD
Sertindole—ADRA1A—telencephalon—brain cancer	0.00115	0.00262	CbGeAlD
Sertindole—ADRA1D—central nervous system—brain cancer	0.00114	0.00259	CbGeAlD
Sertindole—DRD2—telencephalon—brain cancer	0.00113	0.00256	CbGeAlD
Sertindole—KCNH2—telencephalon—brain cancer	0.00111	0.00253	CbGeAlD
Sertindole—HTR1B—midbrain—brain cancer	0.00111	0.00253	CbGeAlD
Sertindole—HTR1B—spinal cord—brain cancer	0.00108	0.00246	CbGeAlD
Sertindole—HTR1D—midbrain—brain cancer	0.00107	0.00245	CbGeAlD
Sertindole—HTR2C—midbrain—brain cancer	0.00106	0.00242	CbGeAlD
Sertindole—HTR2C—spinal cord—brain cancer	0.00104	0.00236	CbGeAlD
Sertindole—SLC6A4—midbrain—brain cancer	0.00101	0.0023	CbGeAlD
Sertindole—SLC6A4—spinal cord—brain cancer	0.000984	0.00224	CbGeAlD
Sertindole—HTR1B—endocrine gland—brain cancer	0.000974	0.00222	CbGeAlD
Sertindole—HTR1B—head—brain cancer	0.000962	0.00219	CbGeAlD
Sertindole—HTR1D—head—brain cancer	0.000931	0.00212	CbGeAlD
Sertindole—ADRA1B—brain—brain cancer	0.000923	0.0021	CbGeAlD
Sertindole—HTR2C—head—brain cancer	0.000922	0.0021	CbGeAlD
Sertindole—DRD2—pituitary gland—brain cancer	0.000917	0.00209	CbGeAlD
Sertindole—KCNH2—pituitary gland—brain cancer	0.000904	0.00206	CbGeAlD
Sertindole—ADRA1D—brain—brain cancer	0.000903	0.00206	CbGeAlD
Sertindole—HTR1A—midbrain—brain cancer	0.000895	0.00204	CbGeAlD
Sertindole—HRH1—telencephalon—brain cancer	0.00089	0.00203	CbGeAlD
Sertindole—SLC6A4—endocrine gland—brain cancer	0.000886	0.00202	CbGeAlD
Sertindole—HTR1B—central nervous system—brain cancer	0.000878	0.002	CbGeAlD
Sertindole—SLC6A4—head—brain cancer	0.000874	0.00199	CbGeAlD
Sertindole—ADRA2A—telencephalon—brain cancer	0.000874	0.00199	CbGeAlD
Sertindole—HTR1A—spinal cord—brain cancer	0.000873	0.00199	CbGeAlD
Sertindole—KCNH2—medulla oblongata—brain cancer	0.000872	0.00199	CbGeAlD
Sertindole—HTR1D—central nervous system—brain cancer	0.00085	0.00194	CbGeAlD
Sertindole—HTR2C—central nervous system—brain cancer	0.000842	0.00192	CbGeAlD
Sertindole—HTR2A—brainstem—brain cancer	0.000837	0.00191	CbGeAlD
Sertindole—DRD2—midbrain—brain cancer	0.000809	0.00184	CbGeAlD
Sertindole—SLC6A4—central nervous system—brain cancer	0.000798	0.00182	CbGeAlD
Sertindole—KCNH2—midbrain—brain cancer	0.000797	0.00181	CbGeAlD
Sertindole—HTR1A—endocrine gland—brain cancer	0.000786	0.00179	CbGeAlD
Sertindole—KCNH2—spinal cord—brain cancer	0.000778	0.00177	CbGeAlD
Sertindole—HTR1A—head—brain cancer	0.000776	0.00177	CbGeAlD
Sertindole—CYP2D6—brainstem—brain cancer	0.000763	0.00174	CbGeAlD
Sertindole—HTR2A—telencephalon—brain cancer	0.000743	0.00169	CbGeAlD
Sertindole—ADRA2A—gonad—brain cancer	0.000729	0.00166	CbGeAlD
Sertindole—ADRA1A—endocrine gland—brain cancer	0.000725	0.00165	CbGeAlD
Sertindole—ADRA1A—head—brain cancer	0.000716	0.00163	CbGeAlD
Sertindole—ADRA2A—pituitary gland—brain cancer	0.000711	0.00162	CbGeAlD
Sertindole—DRD2—endocrine gland—brain cancer	0.00071	0.00162	CbGeAlD
Sertindole—HTR1A—central nervous system—brain cancer	0.000709	0.00161	CbGeAlD
Sertindole—DRD2—head—brain cancer	0.000701	0.0016	CbGeAlD
Sertindole—KCNH2—endocrine gland—brain cancer	0.0007	0.00159	CbGeAlD
Sertindole—HTR1B—brain—brain cancer	0.000697	0.00159	CbGeAlD
Sertindole—HTR1A—cerebellum—brain cancer	0.000693	0.00158	CbGeAlD
Sertindole—KCNH2—head—brain cancer	0.000691	0.00157	CbGeAlD
Sertindole—ADRA2A—medulla oblongata—brain cancer	0.000687	0.00156	CbGeAlD
Sertindole—CYP2D6—telencephalon—brain cancer	0.000677	0.00154	CbGeAlD
Sertindole—HTR1D—brain—brain cancer	0.000675	0.00154	CbGeAlD
Sertindole—HTR2C—brain—brain cancer	0.000668	0.00152	CbGeAlD
Sertindole—ADRA1A—central nervous system—brain cancer	0.000653	0.00149	CbGeAlD
Sertindole—DRD2—central nervous system—brain cancer	0.00064	0.00146	CbGeAlD
Sertindole—ADRA1A—cerebellum—brain cancer	0.000638	0.00145	CbGeAlD
Sertindole—SLC6A4—brain—brain cancer	0.000634	0.00144	CbGeAlD
Sertindole—KCNH2—central nervous system—brain cancer	0.000631	0.00144	CbGeAlD
Sertindole—ADRA2A—midbrain—brain cancer	0.000627	0.00143	CbGeAlD
Sertindole—DRD2—cerebellum—brain cancer	0.000626	0.00142	CbGeAlD
Sertindole—HTR2A—gonad—brain cancer	0.00062	0.00141	CbGeAlD
Sertindole—KCNH2—cerebellum—brain cancer	0.000617	0.0014	CbGeAlD
Sertindole—ADRA2A—spinal cord—brain cancer	0.000612	0.00139	CbGeAlD
Sertindole—HTR2A—pituitary gland—brain cancer	0.000605	0.00138	CbGeAlD
Sertindole—HTR2A—medulla oblongata—brain cancer	0.000584	0.00133	CbGeAlD
Sertindole—HTR1A—brain—brain cancer	0.000563	0.00128	CbGeAlD
Sertindole—HRH1—endocrine gland—brain cancer	0.000561	0.00128	CbGeAlD
Sertindole—HRH1—head—brain cancer	0.000554	0.00126	CbGeAlD
Sertindole—ADRA2A—endocrine gland—brain cancer	0.000551	0.00125	CbGeAlD
Sertindole—ADRA2A—head—brain cancer	0.000544	0.00124	CbGeAlD
Sertindole—HTR2A—midbrain—brain cancer	0.000534	0.00121	CbGeAlD
Sertindole—HTR2A—spinal cord—brain cancer	0.000521	0.00119	CbGeAlD
Sertindole—ADRA1A—brain—brain cancer	0.000519	0.00118	CbGeAlD
Sertindole—DRD2—brain—brain cancer	0.000508	0.00116	CbGeAlD
Sertindole—HRH1—central nervous system—brain cancer	0.000506	0.00115	CbGeAlD
Sertindole—KCNH2—brain—brain cancer	0.000501	0.00114	CbGeAlD
Sertindole—ADRA2A—central nervous system—brain cancer	0.000497	0.00113	CbGeAlD
Sertindole—ADRA2A—cerebellum—brain cancer	0.000485	0.00111	CbGeAlD
Sertindole—HTR2A—endocrine gland—brain cancer	0.000469	0.00107	CbGeAlD
Sertindole—HTR2A—head—brain cancer	0.000463	0.00105	CbGeAlD
Sertindole—CYP3A4—endocrine gland—brain cancer	0.000434	0.000988	CbGeAlD
Sertindole—CYP2D6—endocrine gland—brain cancer	0.000427	0.000972	CbGeAlD
Sertindole—HTR2A—central nervous system—brain cancer	0.000422	0.000961	CbGeAlD
Sertindole—CYP2D6—head—brain cancer	0.000421	0.00096	CbGeAlD
Sertindole—HTR2A—cerebellum—brain cancer	0.000413	0.00094	CbGeAlD
Sertindole—HRH1—brain—brain cancer	0.000401	0.000914	CbGeAlD
Sertindole—ADRA2A—brain—brain cancer	0.000394	0.000898	CbGeAlD
Sertindole—CYP3A4—central nervous system—brain cancer	0.000391	0.00089	CbGeAlD
Sertindole—CYP2D6—central nervous system—brain cancer	0.000385	0.000876	CbGeAlD
Sertindole—CYP2D6—cerebellum—brain cancer	0.000376	0.000856	CbGeAlD
Sertindole—HTR2A—brain—brain cancer	0.000335	0.000763	CbGeAlD
Sertindole—CYP2D6—brain—brain cancer	0.000305	0.000695	CbGeAlD
Sertindole—HTR1D—Signaling Pathways—PIK3CG—brain cancer	2.64e-05	0.000205	CbGpPWpGaD
Sertindole—HTR1D—Signaling Pathways—APC—brain cancer	2.64e-05	0.000205	CbGpPWpGaD
Sertindole—CYP2D6—Metabolism—ENO2—brain cancer	2.63e-05	0.000205	CbGpPWpGaD
Sertindole—ADRA1A—Signaling Pathways—VAV1—brain cancer	2.63e-05	0.000204	CbGpPWpGaD
Sertindole—ADRA2A—Signaling by GPCR—PIK3CG—brain cancer	2.62e-05	0.000204	CbGpPWpGaD
Sertindole—HTR1B—Signaling Pathways—APC—brain cancer	2.59e-05	0.000201	CbGpPWpGaD
Sertindole—HTR1B—Signaling Pathways—PIK3CG—brain cancer	2.59e-05	0.000201	CbGpPWpGaD
Sertindole—HTR1A—GPCR downstream signaling—IL2—brain cancer	2.59e-05	0.000201	CbGpPWpGaD
Sertindole—HTR2C—GPCR downstream signaling—IL2—brain cancer	2.57e-05	0.0002	CbGpPWpGaD
Sertindole—ADRA1D—Signaling Pathways—IRS2—brain cancer	2.56e-05	0.000199	CbGpPWpGaD
Sertindole—DRD3—Signaling Pathways—IRS2—brain cancer	2.56e-05	0.000199	CbGpPWpGaD
Sertindole—ADRA2A—Signaling Pathways—NOTCH2—brain cancer	2.56e-05	0.000199	CbGpPWpGaD
Sertindole—DRD4—Signaling Pathways—PIK3CG—brain cancer	2.55e-05	0.000198	CbGpPWpGaD
Sertindole—DRD4—Signaling Pathways—APC—brain cancer	2.55e-05	0.000198	CbGpPWpGaD
Sertindole—ADRA1B—Signaling Pathways—HES1—brain cancer	2.54e-05	0.000198	CbGpPWpGaD
Sertindole—HTR1A—Signaling Pathways—PDGFRA—brain cancer	2.54e-05	0.000198	CbGpPWpGaD
Sertindole—CYP3A4—Metabolism—BSG—brain cancer	2.53e-05	0.000197	CbGpPWpGaD
Sertindole—HTR2C—Signaling Pathways—PDGFRA—brain cancer	2.53e-05	0.000197	CbGpPWpGaD
Sertindole—HTR1F—Signaling Pathways—VEGFA—brain cancer	2.47e-05	0.000192	CbGpPWpGaD
Sertindole—HTR1A—Signaling Pathways—SPP1—brain cancer	2.47e-05	0.000192	CbGpPWpGaD
Sertindole—ADRA1B—GPCR downstream signaling—IL2—brain cancer	2.46e-05	0.000191	CbGpPWpGaD
Sertindole—HTR2C—Signaling Pathways—SPP1—brain cancer	2.46e-05	0.000191	CbGpPWpGaD
Sertindole—HTR1F—Signaling Pathways—STAT3—brain cancer	2.45e-05	0.00019	CbGpPWpGaD
Sertindole—ADRA2A—Signaling Pathways—VAV1—brain cancer	2.44e-05	0.00019	CbGpPWpGaD
Sertindole—HTR6—Signaling by GPCR—EGFR—brain cancer	2.43e-05	0.000189	CbGpPWpGaD
Sertindole—ADRA1B—Signaling Pathways—PDGFRA—brain cancer	2.42e-05	0.000188	CbGpPWpGaD
Sertindole—HTR1D—Signaling by GPCR—EGFR—brain cancer	2.41e-05	0.000187	CbGpPWpGaD
Sertindole—HTR1B—Signaling by GPCR—EGFR—brain cancer	2.36e-05	0.000183	CbGpPWpGaD
Sertindole—ADRA1B—Signaling Pathways—SPP1—brain cancer	2.35e-05	0.000183	CbGpPWpGaD
Sertindole—HTR1A—Signaling by GPCR—IL2—brain cancer	2.35e-05	0.000182	CbGpPWpGaD
Sertindole—DRD2—Signaling Pathways—HES1—brain cancer	2.35e-05	0.000182	CbGpPWpGaD
Sertindole—HTR2C—Signaling by GPCR—IL2—brain cancer	2.34e-05	0.000182	CbGpPWpGaD
Sertindole—HTR1E—Signaling Pathways—VEGFA—brain cancer	2.33e-05	0.000181	CbGpPWpGaD
Sertindole—DRD4—Signaling by GPCR—EGFR—brain cancer	2.32e-05	0.00018	CbGpPWpGaD
Sertindole—HTR1E—Signaling Pathways—STAT3—brain cancer	2.31e-05	0.000179	CbGpPWpGaD
Sertindole—HTR2A—Signaling Pathways—HES1—brain cancer	2.31e-05	0.000179	CbGpPWpGaD
Sertindole—HRH1—Signaling Pathways—HES1—brain cancer	2.3e-05	0.000179	CbGpPWpGaD
Sertindole—HTR1F—Signaling Pathways—MYC—brain cancer	2.28e-05	0.000177	CbGpPWpGaD
Sertindole—DRD2—GPCR downstream signaling—IL2—brain cancer	2.27e-05	0.000176	CbGpPWpGaD
Sertindole—DRD3—Signaling Pathways—PIK3CG—brain cancer	2.26e-05	0.000176	CbGpPWpGaD
Sertindole—ADRA1D—Signaling Pathways—PIK3CG—brain cancer	2.26e-05	0.000176	CbGpPWpGaD
Sertindole—ADRA1D—Signaling Pathways—APC—brain cancer	2.26e-05	0.000176	CbGpPWpGaD
Sertindole—DRD3—Signaling Pathways—APC—brain cancer	2.26e-05	0.000176	CbGpPWpGaD
Sertindole—ADRA1A—Signaling Pathways—HES1—brain cancer	2.26e-05	0.000175	CbGpPWpGaD
Sertindole—ADRA1B—Signaling by GPCR—IL2—brain cancer	2.24e-05	0.000174	CbGpPWpGaD
Sertindole—HTR2A—GPCR downstream signaling—IL2—brain cancer	2.24e-05	0.000174	CbGpPWpGaD
Sertindole—DRD2—Signaling Pathways—PDGFRA—brain cancer	2.23e-05	0.000173	CbGpPWpGaD
Sertindole—HTR1A—Signaling Pathways—IRS2—brain cancer	2.23e-05	0.000173	CbGpPWpGaD
Sertindole—HRH1—GPCR downstream signaling—IL2—brain cancer	2.23e-05	0.000173	CbGpPWpGaD
Sertindole—HTR1F—Signaling Pathways—EGFR—brain cancer	2.23e-05	0.000173	CbGpPWpGaD
Sertindole—HTR2C—Signaling Pathways—IRS2—brain cancer	2.22e-05	0.000173	CbGpPWpGaD
Sertindole—HTR2A—Signaling Pathways—PDGFRA—brain cancer	2.2e-05	0.000171	CbGpPWpGaD
Sertindole—HRH1—Signaling Pathways—PDGFRA—brain cancer	2.19e-05	0.00017	CbGpPWpGaD
Sertindole—ADRA1A—GPCR downstream signaling—IL2—brain cancer	2.19e-05	0.00017	CbGpPWpGaD
Sertindole—CYP3A4—Metabolism—IDH1—brain cancer	2.18e-05	0.000169	CbGpPWpGaD
Sertindole—DRD2—Signaling Pathways—SPP1—brain cancer	2.17e-05	0.000168	CbGpPWpGaD
Sertindole—ADRA1A—Signaling Pathways—PDGFRA—brain cancer	2.15e-05	0.000167	CbGpPWpGaD
Sertindole—HTR1E—Signaling Pathways—MYC—brain cancer	2.15e-05	0.000167	CbGpPWpGaD
Sertindole—HTR2A—Signaling Pathways—SPP1—brain cancer	2.13e-05	0.000166	CbGpPWpGaD
Sertindole—HRH1—Signaling Pathways—SPP1—brain cancer	2.13e-05	0.000165	CbGpPWpGaD
Sertindole—ADRA1B—Signaling Pathways—IRS2—brain cancer	2.13e-05	0.000165	CbGpPWpGaD
Sertindole—ADRA2A—Signaling Pathways—HES1—brain cancer	2.1e-05	0.000163	CbGpPWpGaD
Sertindole—HTR1E—Signaling Pathways—EGFR—brain cancer	2.1e-05	0.000163	CbGpPWpGaD
Sertindole—ADRA1A—Signaling Pathways—SPP1—brain cancer	2.09e-05	0.000162	CbGpPWpGaD
Sertindole—HTR6—Signaling Pathways—RELA—brain cancer	2.08e-05	0.000162	CbGpPWpGaD
Sertindole—HTR6—Signaling Pathways—ERBB2—brain cancer	2.07e-05	0.000161	CbGpPWpGaD
Sertindole—ADRA2A—Hemostasis—TP53—brain cancer	2.07e-05	0.00016	CbGpPWpGaD
Sertindole—HTR1D—Signaling Pathways—RELA—brain cancer	2.07e-05	0.00016	CbGpPWpGaD
Sertindole—DRD2—Signaling by GPCR—IL2—brain cancer	2.06e-05	0.00016	CbGpPWpGaD
Sertindole—DRD3—Signaling by GPCR—EGFR—brain cancer	2.06e-05	0.00016	CbGpPWpGaD
Sertindole—ADRA1D—Signaling by GPCR—EGFR—brain cancer	2.06e-05	0.00016	CbGpPWpGaD
Sertindole—HTR1D—Signaling Pathways—ERBB2—brain cancer	2.05e-05	0.000159	CbGpPWpGaD
Sertindole—ADRA2A—GPCR downstream signaling—IL2—brain cancer	2.03e-05	0.000158	CbGpPWpGaD
Sertindole—HTR2A—Signaling by GPCR—IL2—brain cancer	2.03e-05	0.000158	CbGpPWpGaD
Sertindole—HRH1—Signaling by GPCR—IL2—brain cancer	2.03e-05	0.000157	CbGpPWpGaD
Sertindole—HTR1B—Signaling Pathways—RELA—brain cancer	2.02e-05	0.000157	CbGpPWpGaD
Sertindole—HTR1B—Signaling Pathways—ERBB2—brain cancer	2.01e-05	0.000156	CbGpPWpGaD
Sertindole—ADRA2A—Signaling Pathways—PDGFRA—brain cancer	2e-05	0.000155	CbGpPWpGaD
Sertindole—DRD4—Signaling Pathways—RELA—brain cancer	1.99e-05	0.000155	CbGpPWpGaD
Sertindole—ADRA1A—Signaling by GPCR—IL2—brain cancer	1.99e-05	0.000154	CbGpPWpGaD
Sertindole—DRD4—Signaling Pathways—ERBB2—brain cancer	1.98e-05	0.000154	CbGpPWpGaD
Sertindole—HTR1A—Signaling Pathways—APC—brain cancer	1.97e-05	0.000153	CbGpPWpGaD
Sertindole—HTR1A—Signaling Pathways—PIK3CG—brain cancer	1.97e-05	0.000153	CbGpPWpGaD
Sertindole—HTR2C—Signaling Pathways—PIK3CG—brain cancer	1.96e-05	0.000152	CbGpPWpGaD
Sertindole—HTR2C—Signaling Pathways—APC—brain cancer	1.96e-05	0.000152	CbGpPWpGaD
Sertindole—DRD2—Signaling Pathways—IRS2—brain cancer	1.96e-05	0.000152	CbGpPWpGaD
Sertindole—ADRA2A—Signaling Pathways—SPP1—brain cancer	1.94e-05	0.000151	CbGpPWpGaD
Sertindole—HTR2A—Signaling Pathways—IRS2—brain cancer	1.93e-05	0.00015	CbGpPWpGaD
Sertindole—HRH1—Signaling Pathways—IRS2—brain cancer	1.93e-05	0.00015	CbGpPWpGaD
Sertindole—ADRA1A—Signaling Pathways—IRS2—brain cancer	1.89e-05	0.000147	CbGpPWpGaD
Sertindole—ADRA1B—Signaling Pathways—APC—brain cancer	1.88e-05	0.000146	CbGpPWpGaD
Sertindole—ADRA1B—Signaling Pathways—PIK3CG—brain cancer	1.88e-05	0.000146	CbGpPWpGaD
Sertindole—HTR6—Signaling Pathways—IL2—brain cancer	1.88e-05	0.000146	CbGpPWpGaD
Sertindole—HTR1F—Signaling Pathways—TP53—brain cancer	1.87e-05	0.000145	CbGpPWpGaD
Sertindole—HTR1D—Signaling Pathways—IL2—brain cancer	1.86e-05	0.000145	CbGpPWpGaD
Sertindole—ADRA2A—Metabolism—PIK3CG—brain cancer	1.85e-05	0.000144	CbGpPWpGaD
Sertindole—ADRA2A—Signaling by GPCR—IL2—brain cancer	1.85e-05	0.000143	CbGpPWpGaD
Sertindole—HTR6—Signaling Pathways—CCND1—brain cancer	1.83e-05	0.000142	CbGpPWpGaD
Sertindole—HTR1B—Signaling Pathways—IL2—brain cancer	1.82e-05	0.000141	CbGpPWpGaD
Sertindole—HTR1D—Signaling Pathways—CCND1—brain cancer	1.81e-05	0.000141	CbGpPWpGaD
Sertindole—HTR6—Signaling Pathways—CTNNB1—brain cancer	1.81e-05	0.000141	CbGpPWpGaD
Sertindole—HTR1A—Signaling by GPCR—EGFR—brain cancer	1.8e-05	0.00014	CbGpPWpGaD
Sertindole—HTR1D—Signaling Pathways—CTNNB1—brain cancer	1.8e-05	0.000139	CbGpPWpGaD
Sertindole—DRD4—Signaling Pathways—IL2—brain cancer	1.79e-05	0.000139	CbGpPWpGaD
Sertindole—HTR2C—Signaling by GPCR—EGFR—brain cancer	1.79e-05	0.000139	CbGpPWpGaD
Sertindole—HTR1B—Signaling Pathways—CCND1—brain cancer	1.78e-05	0.000138	CbGpPWpGaD
Sertindole—ADRA1D—Signaling Pathways—RELA—brain cancer	1.77e-05	0.000137	CbGpPWpGaD
Sertindole—DRD3—Signaling Pathways—RELA—brain cancer	1.77e-05	0.000137	CbGpPWpGaD
Sertindole—HTR1E—Signaling Pathways—TP53—brain cancer	1.76e-05	0.000137	CbGpPWpGaD
Sertindole—HTR1B—Signaling Pathways—CTNNB1—brain cancer	1.76e-05	0.000137	CbGpPWpGaD
Sertindole—ADRA1D—Signaling Pathways—ERBB2—brain cancer	1.76e-05	0.000136	CbGpPWpGaD
Sertindole—DRD3—Signaling Pathways—ERBB2—brain cancer	1.76e-05	0.000136	CbGpPWpGaD
Sertindole—ADRA2A—Signaling Pathways—IRS2—brain cancer	1.76e-05	0.000136	CbGpPWpGaD
Sertindole—DRD4—Signaling Pathways—CCND1—brain cancer	1.75e-05	0.000136	CbGpPWpGaD
Sertindole—DRD2—Signaling Pathways—PIK3CG—brain cancer	1.73e-05	0.000134	CbGpPWpGaD
Sertindole—DRD2—Signaling Pathways—APC—brain cancer	1.73e-05	0.000134	CbGpPWpGaD
Sertindole—DRD4—Signaling Pathways—CTNNB1—brain cancer	1.73e-05	0.000134	CbGpPWpGaD
Sertindole—CYP3A4—Metabolism—ENO2—brain cancer	1.72e-05	0.000134	CbGpPWpGaD
Sertindole—ADRA1B—Signaling by GPCR—EGFR—brain cancer	1.71e-05	0.000133	CbGpPWpGaD
Sertindole—HTR2A—Signaling Pathways—APC—brain cancer	1.7e-05	0.000132	CbGpPWpGaD
Sertindole—HTR2A—Signaling Pathways—PIK3CG—brain cancer	1.7e-05	0.000132	CbGpPWpGaD
Sertindole—HRH1—Signaling Pathways—PIK3CG—brain cancer	1.7e-05	0.000132	CbGpPWpGaD
Sertindole—HRH1—Signaling Pathways—APC—brain cancer	1.7e-05	0.000132	CbGpPWpGaD
Sertindole—ADRA1A—Signaling Pathways—PIK3CG—brain cancer	1.67e-05	0.00013	CbGpPWpGaD
Sertindole—ADRA1A—Signaling Pathways—APC—brain cancer	1.67e-05	0.00013	CbGpPWpGaD
Sertindole—HTR6—Signaling Pathways—VEGFA—brain cancer	1.59e-05	0.000124	CbGpPWpGaD
Sertindole—DRD3—Signaling Pathways—IL2—brain cancer	1.59e-05	0.000124	CbGpPWpGaD
Sertindole—ADRA1D—Signaling Pathways—IL2—brain cancer	1.59e-05	0.000124	CbGpPWpGaD
Sertindole—HTR1D—Signaling Pathways—VEGFA—brain cancer	1.58e-05	0.000123	CbGpPWpGaD
Sertindole—HTR6—Signaling Pathways—STAT3—brain cancer	1.58e-05	0.000123	CbGpPWpGaD
Sertindole—DRD2—Signaling by GPCR—EGFR—brain cancer	1.58e-05	0.000123	CbGpPWpGaD
Sertindole—HTR1D—Signaling Pathways—STAT3—brain cancer	1.57e-05	0.000122	CbGpPWpGaD
Sertindole—ADRA1D—Signaling Pathways—CCND1—brain cancer	1.55e-05	0.000121	CbGpPWpGaD
Sertindole—DRD3—Signaling Pathways—CCND1—brain cancer	1.55e-05	0.000121	CbGpPWpGaD
Sertindole—HTR2A—Signaling by GPCR—EGFR—brain cancer	1.55e-05	0.000121	CbGpPWpGaD
Sertindole—ADRA2A—Signaling Pathways—PIK3CG—brain cancer	1.55e-05	0.00012	CbGpPWpGaD
Sertindole—ADRA2A—Signaling Pathways—APC—brain cancer	1.55e-05	0.00012	CbGpPWpGaD
Sertindole—HRH1—Signaling by GPCR—EGFR—brain cancer	1.55e-05	0.00012	CbGpPWpGaD
Sertindole—HTR1B—Signaling Pathways—VEGFA—brain cancer	1.55e-05	0.00012	CbGpPWpGaD
Sertindole—HTR1A—Signaling Pathways—RELA—brain cancer	1.54e-05	0.00012	CbGpPWpGaD
Sertindole—ADRA1D—Signaling Pathways—CTNNB1—brain cancer	1.54e-05	0.000119	CbGpPWpGaD
Sertindole—DRD3—Signaling Pathways—CTNNB1—brain cancer	1.54e-05	0.000119	CbGpPWpGaD
Sertindole—HTR2C—Signaling Pathways—RELA—brain cancer	1.53e-05	0.000119	CbGpPWpGaD
Sertindole—HTR1B—Signaling Pathways—STAT3—brain cancer	1.53e-05	0.000119	CbGpPWpGaD
Sertindole—HTR1A—Signaling Pathways—ERBB2—brain cancer	1.53e-05	0.000119	CbGpPWpGaD
Sertindole—DRD4—Signaling Pathways—VEGFA—brain cancer	1.52e-05	0.000118	CbGpPWpGaD
Sertindole—HTR2C—Signaling Pathways—ERBB2—brain cancer	1.52e-05	0.000118	CbGpPWpGaD
Sertindole—ADRA1A—Signaling by GPCR—EGFR—brain cancer	1.52e-05	0.000118	CbGpPWpGaD
Sertindole—DRD4—Signaling Pathways—STAT3—brain cancer	1.51e-05	0.000117	CbGpPWpGaD
Sertindole—ADRA1B—Signaling Pathways—RELA—brain cancer	1.47e-05	0.000114	CbGpPWpGaD
Sertindole—HTR6—Signaling Pathways—MYC—brain cancer	1.47e-05	0.000114	CbGpPWpGaD
Sertindole—ADRA1B—Signaling Pathways—ERBB2—brain cancer	1.46e-05	0.000113	CbGpPWpGaD
Sertindole—HTR1D—Signaling Pathways—MYC—brain cancer	1.46e-05	0.000113	CbGpPWpGaD
Sertindole—HTR6—Signaling Pathways—EGFR—brain cancer	1.43e-05	0.000111	CbGpPWpGaD
Sertindole—HTR1B—Signaling Pathways—MYC—brain cancer	1.43e-05	0.000111	CbGpPWpGaD
Sertindole—HTR1D—Signaling Pathways—EGFR—brain cancer	1.42e-05	0.000111	CbGpPWpGaD
Sertindole—ADRA2A—Signaling by GPCR—EGFR—brain cancer	1.41e-05	0.00011	CbGpPWpGaD
Sertindole—DRD4—Signaling Pathways—MYC—brain cancer	1.4e-05	0.000109	CbGpPWpGaD
Sertindole—HTR1B—Signaling Pathways—EGFR—brain cancer	1.39e-05	0.000108	CbGpPWpGaD
Sertindole—HTR1A—Signaling Pathways—IL2—brain cancer	1.39e-05	0.000108	CbGpPWpGaD
Sertindole—HTR2C—Signaling Pathways—IL2—brain cancer	1.38e-05	0.000107	CbGpPWpGaD
Sertindole—DRD4—Signaling Pathways—EGFR—brain cancer	1.37e-05	0.000106	CbGpPWpGaD
Sertindole—ADRA1D—Signaling Pathways—VEGFA—brain cancer	1.35e-05	0.000105	CbGpPWpGaD
Sertindole—DRD3—Signaling Pathways—VEGFA—brain cancer	1.35e-05	0.000105	CbGpPWpGaD
Sertindole—DRD2—Signaling Pathways—RELA—brain cancer	1.35e-05	0.000105	CbGpPWpGaD
Sertindole—HTR1A—Signaling Pathways—CCND1—brain cancer	1.35e-05	0.000105	CbGpPWpGaD
Sertindole—HTR2C—Signaling Pathways—CCND1—brain cancer	1.35e-05	0.000105	CbGpPWpGaD
Sertindole—DRD2—Signaling Pathways—ERBB2—brain cancer	1.34e-05	0.000104	CbGpPWpGaD
Sertindole—ADRA1D—Signaling Pathways—STAT3—brain cancer	1.34e-05	0.000104	CbGpPWpGaD
Sertindole—DRD3—Signaling Pathways—STAT3—brain cancer	1.34e-05	0.000104	CbGpPWpGaD
Sertindole—HTR1A—Signaling Pathways—CTNNB1—brain cancer	1.34e-05	0.000104	CbGpPWpGaD
Sertindole—HTR2C—Signaling Pathways—CTNNB1—brain cancer	1.33e-05	0.000104	CbGpPWpGaD
Sertindole—HTR2A—Signaling Pathways—RELA—brain cancer	1.33e-05	0.000103	CbGpPWpGaD
Sertindole—HRH1—Signaling Pathways—RELA—brain cancer	1.33e-05	0.000103	CbGpPWpGaD
Sertindole—HTR2A—Signaling Pathways—ERBB2—brain cancer	1.32e-05	0.000103	CbGpPWpGaD
Sertindole—ADRA1B—Signaling Pathways—IL2—brain cancer	1.32e-05	0.000103	CbGpPWpGaD
Sertindole—HRH1—Signaling Pathways—ERBB2—brain cancer	1.32e-05	0.000103	CbGpPWpGaD
Sertindole—ADRA1A—Signaling Pathways—RELA—brain cancer	1.3e-05	0.000101	CbGpPWpGaD
Sertindole—ADRA1A—Signaling Pathways—ERBB2—brain cancer	1.3e-05	0.000101	CbGpPWpGaD
Sertindole—ADRA1B—Signaling Pathways—CCND1—brain cancer	1.29e-05	0.0001	CbGpPWpGaD
Sertindole—ADRA1B—Signaling Pathways—CTNNB1—brain cancer	1.28e-05	9.91e-05	CbGpPWpGaD
Sertindole—ADRA1D—Signaling Pathways—MYC—brain cancer	1.25e-05	9.67e-05	CbGpPWpGaD
Sertindole—DRD3—Signaling Pathways—MYC—brain cancer	1.25e-05	9.67e-05	CbGpPWpGaD
Sertindole—DRD2—Signaling Pathways—IL2—brain cancer	1.22e-05	9.46e-05	CbGpPWpGaD
Sertindole—ADRA1D—Signaling Pathways—EGFR—brain cancer	1.22e-05	9.46e-05	CbGpPWpGaD
Sertindole—DRD3—Signaling Pathways—EGFR—brain cancer	1.22e-05	9.46e-05	CbGpPWpGaD
Sertindole—ADRA2A—Signaling Pathways—RELA—brain cancer	1.21e-05	9.41e-05	CbGpPWpGaD
Sertindole—CYP2D6—Metabolism—PIK3CG—brain cancer	1.21e-05	9.38e-05	CbGpPWpGaD
Sertindole—HTR6—Signaling Pathways—TP53—brain cancer	1.2e-05	9.35e-05	CbGpPWpGaD
Sertindole—ADRA2A—Signaling Pathways—ERBB2—brain cancer	1.2e-05	9.35e-05	CbGpPWpGaD
Sertindole—HTR2A—Signaling Pathways—IL2—brain cancer	1.2e-05	9.31e-05	CbGpPWpGaD
Sertindole—HRH1—Signaling Pathways—IL2—brain cancer	1.2e-05	9.29e-05	CbGpPWpGaD
Sertindole—HTR1D—Signaling Pathways—TP53—brain cancer	1.2e-05	9.28e-05	CbGpPWpGaD
Sertindole—DRD2—Signaling Pathways—CCND1—brain cancer	1.19e-05	9.23e-05	CbGpPWpGaD
Sertindole—HTR1A—Signaling Pathways—VEGFA—brain cancer	1.18e-05	9.16e-05	CbGpPWpGaD
Sertindole—DRD2—Signaling Pathways—CTNNB1—brain cancer	1.18e-05	9.14e-05	CbGpPWpGaD
Sertindole—ADRA1A—Signaling Pathways—IL2—brain cancer	1.17e-05	9.12e-05	CbGpPWpGaD
Sertindole—HTR2C—Signaling Pathways—VEGFA—brain cancer	1.17e-05	9.11e-05	CbGpPWpGaD
Sertindole—HTR1B—Signaling Pathways—TP53—brain cancer	1.17e-05	9.09e-05	CbGpPWpGaD
Sertindole—HTR2A—Signaling Pathways—CCND1—brain cancer	1.17e-05	9.08e-05	CbGpPWpGaD
Sertindole—HTR1A—Signaling Pathways—STAT3—brain cancer	1.17e-05	9.07e-05	CbGpPWpGaD
Sertindole—HRH1—Signaling Pathways—CCND1—brain cancer	1.17e-05	9.06e-05	CbGpPWpGaD
Sertindole—HTR2C—Signaling Pathways—STAT3—brain cancer	1.16e-05	9.02e-05	CbGpPWpGaD
Sertindole—HTR2A—Signaling Pathways—CTNNB1—brain cancer	1.16e-05	8.99e-05	CbGpPWpGaD
Sertindole—HRH1—Signaling Pathways—CTNNB1—brain cancer	1.16e-05	8.97e-05	CbGpPWpGaD
Sertindole—DRD4—Signaling Pathways—TP53—brain cancer	1.15e-05	8.94e-05	CbGpPWpGaD
Sertindole—ADRA1A—Signaling Pathways—CCND1—brain cancer	1.14e-05	8.89e-05	CbGpPWpGaD
Sertindole—ADRA1A—Signaling Pathways—CTNNB1—brain cancer	1.13e-05	8.8e-05	CbGpPWpGaD
Sertindole—ADRA1B—Signaling Pathways—VEGFA—brain cancer	1.12e-05	8.72e-05	CbGpPWpGaD
Sertindole—ADRA1B—Signaling Pathways—STAT3—brain cancer	1.11e-05	8.64e-05	CbGpPWpGaD
Sertindole—ADRA2A—Signaling Pathways—IL2—brain cancer	1.09e-05	8.47e-05	CbGpPWpGaD
Sertindole—HTR1A—Signaling Pathways—MYC—brain cancer	1.09e-05	8.43e-05	CbGpPWpGaD
Sertindole—HTR2C—Signaling Pathways—MYC—brain cancer	1.08e-05	8.38e-05	CbGpPWpGaD
Sertindole—ADRA2A—Signaling Pathways—CCND1—brain cancer	1.06e-05	8.26e-05	CbGpPWpGaD
Sertindole—HTR1A—Signaling Pathways—EGFR—brain cancer	1.06e-05	8.24e-05	CbGpPWpGaD
Sertindole—HTR2C—Signaling Pathways—EGFR—brain cancer	1.06e-05	8.2e-05	CbGpPWpGaD
Sertindole—ADRA2A—Signaling Pathways—CTNNB1—brain cancer	1.05e-05	8.18e-05	CbGpPWpGaD
Sertindole—DRD2—Signaling Pathways—VEGFA—brain cancer	1.04e-05	8.04e-05	CbGpPWpGaD
Sertindole—ADRA1B—Signaling Pathways—MYC—brain cancer	1.03e-05	8.03e-05	CbGpPWpGaD
Sertindole—DRD2—Signaling Pathways—STAT3—brain cancer	1.03e-05	7.96e-05	CbGpPWpGaD
Sertindole—ADRA1D—Signaling Pathways—TP53—brain cancer	1.02e-05	7.94e-05	CbGpPWpGaD
Sertindole—DRD3—Signaling Pathways—TP53—brain cancer	1.02e-05	7.94e-05	CbGpPWpGaD
Sertindole—HTR2A—Signaling Pathways—VEGFA—brain cancer	1.02e-05	7.91e-05	CbGpPWpGaD
Sertindole—HRH1—Signaling Pathways—VEGFA—brain cancer	1.02e-05	7.9e-05	CbGpPWpGaD
Sertindole—ADRA1B—Signaling Pathways—EGFR—brain cancer	1.01e-05	7.85e-05	CbGpPWpGaD
Sertindole—HTR2A—Signaling Pathways—STAT3—brain cancer	1.01e-05	7.84e-05	CbGpPWpGaD
Sertindole—HRH1—Signaling Pathways—STAT3—brain cancer	1.01e-05	7.82e-05	CbGpPWpGaD
Sertindole—ADRA1A—Signaling Pathways—VEGFA—brain cancer	9.98e-06	7.75e-05	CbGpPWpGaD
Sertindole—ADRA1A—Signaling Pathways—STAT3—brain cancer	9.88e-06	7.67e-05	CbGpPWpGaD
Sertindole—DRD2—Signaling Pathways—MYC—brain cancer	9.53e-06	7.4e-05	CbGpPWpGaD
Sertindole—HTR2A—Signaling Pathways—MYC—brain cancer	9.38e-06	7.28e-05	CbGpPWpGaD
Sertindole—HRH1—Signaling Pathways—MYC—brain cancer	9.36e-06	7.27e-05	CbGpPWpGaD
Sertindole—DRD2—Signaling Pathways—EGFR—brain cancer	9.32e-06	7.24e-05	CbGpPWpGaD
Sertindole—ADRA2A—Signaling Pathways—VEGFA—brain cancer	9.27e-06	7.2e-05	CbGpPWpGaD
Sertindole—ADRA1A—Signaling Pathways—MYC—brain cancer	9.18e-06	7.13e-05	CbGpPWpGaD
Sertindole—ADRA2A—Signaling Pathways—STAT3—brain cancer	9.18e-06	7.13e-05	CbGpPWpGaD
Sertindole—HTR2A—Signaling Pathways—EGFR—brain cancer	9.17e-06	7.12e-05	CbGpPWpGaD
Sertindole—HRH1—Signaling Pathways—EGFR—brain cancer	9.15e-06	7.11e-05	CbGpPWpGaD
Sertindole—ADRA1A—Signaling Pathways—EGFR—brain cancer	8.98e-06	6.97e-05	CbGpPWpGaD
Sertindole—HTR1A—Signaling Pathways—TP53—brain cancer	8.92e-06	6.92e-05	CbGpPWpGaD
Sertindole—HTR2C—Signaling Pathways—TP53—brain cancer	8.87e-06	6.89e-05	CbGpPWpGaD
Sertindole—ADRA2A—Signaling Pathways—MYC—brain cancer	8.53e-06	6.62e-05	CbGpPWpGaD
Sertindole—ADRA1B—Signaling Pathways—TP53—brain cancer	8.49e-06	6.59e-05	CbGpPWpGaD
Sertindole—ADRA2A—Signaling Pathways—EGFR—brain cancer	8.35e-06	6.48e-05	CbGpPWpGaD
Sertindole—CYP3A4—Metabolism—PIK3CG—brain cancer	7.9e-06	6.13e-05	CbGpPWpGaD
Sertindole—DRD2—Signaling Pathways—TP53—brain cancer	7.83e-06	6.08e-05	CbGpPWpGaD
Sertindole—HTR2A—Signaling Pathways—TP53—brain cancer	7.7e-06	5.98e-05	CbGpPWpGaD
Sertindole—HRH1—Signaling Pathways—TP53—brain cancer	7.69e-06	5.97e-05	CbGpPWpGaD
Sertindole—ADRA1A—Signaling Pathways—TP53—brain cancer	7.54e-06	5.85e-05	CbGpPWpGaD
Sertindole—ADRA2A—Signaling Pathways—TP53—brain cancer	7.01e-06	5.44e-05	CbGpPWpGaD
